National guideline for the management of non-gonococcal urethritis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases)
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017963:Azithromycin / Q000627:therapeutic use; D002690:Chlamydia Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000635:transmission; D002692:Chlamydia trachomatis / Q000302:isolation & purification; D002751:Chlortetracycline / Q000627:therapeutic use; D016358:Contact Tracing; D003707:Demeclocycline / Q000627:therapeutic use; D004318:Doxycycline / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D004917:Erythromycin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D015242:Ofloxacin / Q000627:therapeutic use; D012008:Recurrence; D013752:Tetracycline / Q000627:therapeutic use; D014526:Urethritis / Q000188:drug therapy* / Q000382:microbiology
D000900:Anti-Bacterial Agents; D003707:Demeclocycline; D004917:Erythromycin; C022225:deteclo; D017963:Azithromycin; D015242:Ofloxacin; D013752:Tetracycline; D004318:Doxycycline; D002751:Chlortetracycline